IN THE NEWS
Izotropic Files Pre-Submission Application with U.S. FDA
VANCOUVER, BC –August 18, 2020 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) is pleased to announce that it...
Read More >
Toronto Innovation Acceleration Partners
Do you know that Family Offices are interested in investing in health sciences? TIAP gathers professionals from Family Offices to discuss their investment outlook and...
Read More >
Izotropic Corporation Appoints Executive Vice President of Commercial Operations
VANCOUVER, BC – July 6, 2020 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) is pleased to announce the...
Read More >
Toronto Innovation Acceleration Partners Welcoming Dr. John McGraw
Please join us in welcoming Dr. John McGraw, https://bit.ly/2TS6Han, who has joined our team as EIR. His strong operational & strategic experience will be an...
Read More >
Izotropic Engages StarFish Medical for Design and Development of Commercial Breast CT Model
VANCOUVER, BC – May 13, 2020 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) is pleased to announce it...
Read More >
Izotropic Engages StarFish Medical for Design and Development of Commercial Breast CT Model
VANCOUVER, BC – May 13, 2020 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) is pleased to announce it...
Read More >